| Name | Title | Contact Details |
|---|
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.
Chase Brexton is an equal opportunity employer committed to providing all employees, patients, applicants, and visitors with a safe and supportive environment. Everyone is welcomed and accepted, regardless of race, gender, nation of origin, sexual orientation, gender identity, marital status, religion, socio-economic status, veteran status, or disability. Minority applicants are strongly encouraged to apply. Part of our vision at Chase Brexton is to empower our staff and foster a culture that promotes staff development and satisfaction. We believe our staff is key to achieving our mission to provide compassionate, quality health care that honors diversity, inspires wellness, and improves our communities. Our work is not possible without a strong, devoted, and talented staff. Chase Brexton offers a comprehensive benefits package including medical and dental insurance, vacation, sick leave, paid holidays, long- and short-term disability, life insurance, tuition reimbursement, an Employee Assistance Program, and a tax-free retirement plan with company matching contributions. All in a professional, supportive environment.
Loretto is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pharmacyclics is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sunnyvale, CA. To find more information about Pharmacyclics, please visit www.pcyc.com
BlackSea Technologies is a naval technology firm that enables new asymmetric strategies so U.S. Naval and military forces can prevail over the next several decades in multi-dimensional conflicts.